Dow Up 2.00% Nasdaq Up 1.66%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
1.64 Down 0.01(0.61%) Feb 12, 4:00PM EST
|After Hours : 1.65 Up 0.01 (0.61%) Feb 12, 7:32PM EST
Prev Close:1.65
Open:1.67
Bid:1.25 x 400
Ask:1.68 x 1000
1y Target Est:5.25
Beta:2.67005
Earnings Date:Feb 23 - Feb 29 (Est.)
Day's Range:1.57 - 1.67
52wk Range:1.39 - 9.37
Volume:867,726
Avg Vol (3m):2,365,640
Market Cap:238.53M
P/E (ttm):N/A
EPS (ttm):-0.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 0.61%238.53M
GSKUp 1.56%96.22B
ABTUp 2.17%55.39B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.65
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.50
Quarterly EPS Est (Dec-15) :-0.08
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):0.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback